Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Unlock your academic potential and expand your network by joining us!

Shannon A Bainbridge

Dr. Shannon A Bainbridge

Share Link

Share

Information

Prof. Dr. Shannon A. Bainbridge is an Assistant Professor in the Interdisciplinary School of Health Sciences, Faculty of Medicine, University of Ottawa, with cross-appointment to the Department of Cellular and Molecular Medicine and affiliate investigator status at the Ottawa Hospital Research Institute (OHRI). She obtained her Ph.D. from Queen’s University (Department of Anatomy and Cell Biology). She went on to complete two post-doctoral fellowships. Her current research program addresses two common and debilitating complications of pregnancy: preeclampsia and intrauterine growth restriction. Her research program aims to: (1) understand the molecular basis of these complications within the placenta; (2) identify molecular subclasses of these complications; (3) identify unique biomarkers that can be used to screen and identify these different subclasses of disease; and (4) identify molecular candidates within the placenta that can be targeted for tailored therapeutic treatment of the different subclasses of disease. The methodology used within her laboratory includes gene and protein analyses, in vitro cell/tissue culture, and in vivo models.

Research Keywords & Expertise

CVD
Pregnancy
Placenta
preeclampsia
DOHaD

Fingerprints

Pregnancy
Placenta
preeclampsia
fetal growth restriction
CVD
Machine Learning , AI
DOHaD

Short Biography

Prof. Dr. Shannon A. Bainbridge is an Assistant Professor in the Interdisciplinary School of Health Sciences, Faculty of Medicine, University of Ottawa, with cross-appointment to the Department of Cellular and Molecular Medicine and affiliate investigator status at the Ottawa Hospital Research Institute (OHRI). She obtained her Ph.D. from Queen’s University (Department of Anatomy and Cell Biology). She went on to complete two post-doctoral fellowships. Her current research program addresses two common and debilitating complications of pregnancy: preeclampsia and intrauterine growth restriction. Her research program aims to: (1) understand the molecular basis of these complications within the placenta; (2) identify molecular subclasses of these complications; (3) identify unique biomarkers that can be used to screen and identify these different subclasses of disease; and (4) identify molecular candidates within the placenta that can be targeted for tailored therapeutic treatment of the different subclasses of disease. The methodology used within her laboratory includes gene and protein analyses, in vitro cell/tissue culture, and in vivo models.